Strasbourg, France

Olivier Meyer


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Olivier Meyer: Innovator in Drug Delivery Technologies

Introduction

Olivier Meyer is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of drug delivery and diagnostic imaging. With a total of two patents to his name, his work focuses on innovative techniques that enhance the efficacy of medical treatments.

Latest Patents

Meyer’s latest patents include a technique to monitor drug delivery noninvasively in vivo. This invention relates to diagnostic imaging, specifically monitoring drug delivery using non-invasive imaging techniques. It provides imaging agents and compositions useful for various imaging modalities, including NMR, computed tomography, scintigraphy, and PET. His second patent involves pH-sensitive, serum-stable liposomes. This invention offers novel liposomes that are both pH-sensitive and stable in serum, enhancing their application in drug delivery systems.

Career Highlights

Throughout his career, Olivier Meyer has worked with prestigious institutions, including the University of California and Philipp Lang. His innovative approaches have positioned him as a key figure in the development of advanced drug delivery systems.

Collaborations

Meyer has collaborated with notable professionals in his field, including Demetrios P Papahadjopoulos and Jean-Christophe Leroux. These collaborations have further enriched his research and contributions to the scientific community.

Conclusion

Olivier Meyer’s work in drug delivery technologies exemplifies the impact of innovation in healthcare. His patents reflect a commitment to improving medical treatments through advanced imaging and drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…